April 16, 2018
Attn: Kinamed Agents,
Great news! We have two large mailings going out right now as follows:
- CarboJet mailing to all DePuy Attune® Knee users – This mailing includes the attached cover letter along with a reprint of our new, hot off the press CarboJet ad and the linked study by R. Michael Meneghini, MD (on tourniquetless TKA reducing opioid use in female patients). As you know the Attune Knee has had issues with loosening that DePuy attributes to lipids contamination of the cement/implant interface. We believe that removing much of the lipids and other fluid debris with CarboJet prior to implant impaction can reduce this sort of contamination, while at the same time improve bonding at the cement/bone interface.
[See related blog posts and support materials]
- KineMatch® PFR mailing to all DePuy UKA users – this separate mailing includes a cover letter (also attached) along with our new KineMatch ad and the linked study . The study illustrates the 100% good to excellent results obtained with the KineMatch Patient-Specific approach at average 11 year follow-up. As you may have heard, the DePuy Sigma HP PFJ implant was recently pulled from the market due to poor clinical results. Many former users of this DePuy device are now actively searching for alternative products so reaching out to them now is timely!
[See related blog post on the market exit of the Sigma PFR]
To make it easy for all of you to see who in your territory will be receiving these mailings, I’ve sorted each attached list by state so you can quickly find and follow up with your surgeons. Please let us know if there is any way I can assist you with follow-up. We will of course inform you right away of any response we receive so that you can follow up promptly.
We’re very excited about this well-timed opportunity to boost sales of both CarboJet and KineMatch PFR!
Best Regards,
Joseph Larievy
Marketing Support Coordinator
Kinamed, Inc.
tel: 1-805-384-2748 x 213
fax: 1-805-384-2792
Confidentiality Notice: The information contained in this email, including any attachments, is intended only for the listed recipient(s) and may be privileged, confidential, and legally protected from disclosure. Dissemination, copying, or use of or reliance upon this email by or to anyone other than the listed recipient(s) is prohibited. If you are not the intended recipient, or if this email has been sent to you in error, please notify the sender immediately and destroy any and all copies of this email including any attachments.